Sally Roufail

Sally Roufail

Tumour Angiogenesis Program, Peter MacCallum Cancer Centre

Affiliated withPeter MacCallum Cancer Centre

Research Area

Biology

Biography

Sally Roufail has not added Biography.
If you are Sally Roufail and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

Article Total : 1	Year
Publication title	2016

Other Publications

Article	Year
The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer. Growth factors (Chur, Switzerland)\| PubMed ID: 12148568	2002
Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mi... The Journal of biological chemistry\| PubMed ID: 12867434	2003
Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. The Journal of experimental medicine\| PubMed ID: 12963694	2003
Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Molecular and cellular biology\| PubMed ID: 15743836	2005
Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 17242158	2007
Molecular pathways for lymphangiogenesis and their role in human disease. Novartis Foundation symposium\| PubMed ID: 17534064	2007
The VD1 neutralizing antibody to vascular endothelial growth factor-D: binding epitope and relationship to receptor binding. Journal of molecular biology\| PubMed ID: 21315726	2011
Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 21515745	2011
Preparation of human vascular endothelial growth factor-D for structural and preclinical therapeutic studies. Protein expression and purification\| PubMed ID: 22261343	2012
VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer cell\| PubMed ID: 22340592	2012
The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology. The Journal of biological chemistry\| PubMed ID: 23404505	2013
Vascular endothelial growth factor-d modulates caliber and function of initial lymphatics in the dermis. The Journal of investigative dermatology\| PubMed ID: 23439394	2013
Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis. Clinical & experimental metastasis\| PubMed ID: 23591595	2013
Vegf-d promotes pulmonary oedema in hyperoxic acute lung injury. The Journal of pathology\| PubMed ID: 26924464	2016